Daxor Return on Tangible Equity 2010-2011 | DXR

Current and historical return on tangible equity values for Daxor (DXR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Daxor Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2011-12-31 $-0.01B $0.04B -14.46%
2011-09-30 $0.00B $0.04B -6.78%
2011-06-30 $0.00B $0.05B 8.56%
2011-03-31 $0.00B $0.05B 8.70%
2010-12-31 $0.01B $0.05B 10.81%
2010-09-30 $0.00B $0.05B 4.30%
2010-06-30 $0.00B $0.04B 4.26%
2010-03-31 $0.01B $0.05B 16.84%
2009-12-31 $0.01B $0.05B 13.71%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.048B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.751B 19.46
Encompass Health (EHC) United States $11.999B 25.44
DaVita (DVA) United States $10.763B 15.13
Elanco Animal Health (ELAN) United States $7.271B 15.57
Chemed (CHE) United States $6.922B 21.75
Option Care Health (OPCH) United States $5.102B 22.75
RadNet (RDNT) United States $4.217B 267.62
Amedisys (AMED) United States $3.154B 21.21
Addus HomeCare (ADUS) United States $2.058B 22.60
LifeStance Health (LFST) United States $1.863B 0.00
Astrana Health (ASTH) United States $1.417B 35.11
U.S Physical Therapy (USPH) United States $1.248B 32.21
Aveanna Healthcare Holdings (AVAH) United States $0.907B 51.67
Pennant (PNTG) United States $0.907B 33.29
Atai Life Sciences (ATAI) Germany $0.555B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.040B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00